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self-renewing divisions. Distinct subsets of human memory B cells pre-
fer one of these fates vs. the others. These functional traits largely segre-
gate with the isotype of the B cell receptor. IgM-expressing memory B
cells tend to re-initiate germinal centers, while IgG isotype-switched
memory B cells yield plasmablasts and plasma cells (Seifert et al.,
2015). Yet in the context of secondary DENV infections in humans, itDengue virus
Memory B cellsDengue virus (DENV) is a mosquito-borne ﬂavivirus that infects an
estimated 400 million people each year, with one-third of the world's
population at risk (WHO, 2009). Dengue infections can be caused by
any one of four stereotypically distinct viruses: DENV1–4. A primary in-
fection by one DENV serotype provides lifelong immunity to that sero-
type, but only short-term immunity to the other serotypes (Sabin,
1952). Moreover, in contrast to a primary DENV infection, secondary
heterologous DENV infection increases the risk of hemorrhagic fever
(Nimmannitya et al., 1969). This increased risk is thought to be due to
antibody-dependent enhancement of infection and original antigenic
sin. Antibody-dependent enhancement occurs when sub-neutralizing
antibodies bind to surface Fc receptors that facilitate enhanced viral up-
take (Halstead and O'Rourke, 1977). Original antigenic sin occurs when
memory lymphocytes generated during a primary infectionweakly rec-
ognize non-neutralizing epitopes yet preferentially expand during sec-
ondary infections by related but distinct viruses (Halstead et al.,
1983). This leads to an antibody response that preferentially recognizes
the original, rather than the secondary virus. A major challenge is thus
to develop vaccines that avoid these problems and provide protection
against all four DENV serotypes. For this purpose, an understanding of
the epitope-speciﬁcities of responding B cells during pathogenic sec-
ondary DENV infections is needed. This information in turn may help
develop epitopes for subunit vaccines that elicit neutralizing, rather
than infection-enhancing antibody responses.
During recall responses, memory B cells can differentiate into
antibody-secreting plasmablasts and plasma cells, re-initiate germinalm.2016.09.003.
.
. This is an open access article undercenters for afﬁnitymaturation towards the new pathogen, and undergo
is unclear how pre-existing memory B cells behave. Are all Dengue-
speciﬁc memory B cells recruited into the response? Or do only certain
subsets respond? In this issue, Appanna et al. demonstrate that IgG
memory B cell-derived plasmablasts formed during the acute phase of
secondary infection have a non-overlapping clonal repertoire compared
with that of memory B cells at convalescence (Appanna et al., 2016).
These data agree with and extend upon similar studies by other groups
(Priyamvada et al., 2016).
Antibodies followingDENV infection can bedirected at envelope (E),
pre-membrane (prM), and capsid proteins, and non-structural proteins
1, 3, and 5. Appanna and colleagues show that antibodies derived from
plasmablasts are almost exclusively speciﬁc to the E protein whereas
antibodies derived from DENV-speciﬁc memory B cells can recognize
E, prM or non-structural proteins. A few plasmablast cloneswere specif-
ic for the primary, rather than the secondary virus, indicative of original
antigenic sin. Yet the overwhelming majority of these plasmablasts
were cross-reactive across multiple different DENV serotypes. Though
numbers were somewhat limited, monoclonal antibodies from
plasmablasts tended to be more potent neutralizers relative to antibod-
ies derived from memory B cells. In addition to differences in antigen
speciﬁcity between the plasmablasts and memory B cells, Appanna
et al. also found minimal immunoglobulin gene overlap through reper-
toire sequencing. Thus, it appears that not all DENV-speciﬁc memory B
cells respond to generate circulating plasmablasts during secondary in-
fections. This suggests that there are at least two “types” of memory B
cells: a subset that is predisposed to becoming plasmablasts during sec-
ondary DENV infections, and another subset that either fails to respond
or is biased towards maintaining memory B cell identity.
The observation that B cell subsets possess different antigen speciﬁc-
ities following subunit vaccination or ﬂavivirus infection is not new
(Lavinder et al., 2014; Purtha et al., 2011), but given the issues of
antibody-dependent enhancement and original antigenic sin, human
responses to DENVwarrant deeper exploration. Appanna et al. thus ad-
dress an important aspect in DENV immunity: how can effective and ef-
ﬁcient antibody responses be evaluated? The authors' data suggest thatthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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correlate of one component of long-term immunity against DENV: di-
versity of the memory B cell compartment. The extent to which these
antibodies may instead continue to be produced by bone marrow-
resident long-lived plasma cells or enhance infections remains un-
known. It also remains unknown why only a subset of memory B cells
is recruited into the circulating plasmablast pool. Are the pre-existing
antibody afﬁnities of memory B cells different between E vs. prM or
non-structural proteins? Or are other subsets of plasmablasts in fact
formed but retained in secondary lymphoid organs? How can the de-
sired speciﬁcities of memory B cells be preferentially recruited into
the response by vaccination? These questions will be important to ad-
dress as the basic biology of responses to DENV infections continues to
instruct future vaccine design.
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